Takeshi Kuboyama
Strategy Head of Research AceRNA Technologies
Dr. Kuboyama has experience across chemistry, nucleic acid therapeutics, and drug delivery, gained through roles at Kyowa Kirin, RIKEN, and Nissan Chemical. He is currently responsible for research planning and external collaborations at aceRNA, focusing on the medical application of RNA switch™ technology.
Seminars
Thursday 12th November 2026
Organ- & Cell-Specific Translation Enabled by RNA Switch™ Technology
3:00 pm
- Explore ON- and OFF-translational control using endogenous microRNAs as organ- and cell- specific markers
- Outline design principles for specific translation based on RNA Switch™ technology
- Discover immune cell–selective translation enabled by RNA Switches and its applications
